ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2016
[Clinical Epidemiology and Histological Characteristics of 3,663 Lung Cancer Patients in Sichuan Province from 2008 to 2013].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- [Pulmonary Nodules/Lung Cancer Comprehensive Management Mode: Design and Application].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020Article
- Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice.Chinese journal of cancer · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung cancer is the most common malignancy and is the leading cause of cancer-related death worldwide. Thus, this disease severely threatens human health. This study aims to identify the clinical epidemiology and histological characteristics of lung cancer patients in Sichuan areas.
methodsWe enrolled 3,761 lung-cancer patients who were identified as residents of Sichuan province and treated in West China Hospital from 2008 to 2013.
resultsA total of 3,663 patients from Central, Southern, North, and Western areas in Sichuan province, respectively, were enrolled. The average age of patients was 59.6 years, and patients were predominantly male (68.4%). Significant statistical differences were observed among the average age of patients, male, and pathological types in different regions (all P<0.05). In addition, compared with the 2008 group, the 2013 group had lower rates of adenocarcinoma and squamous-cell carcinoma but higher rates of early-stage lung cancer and lymph-node metastasis. After a three-year follow-up of 1,003 cases, results showed that the 3-year overall survival (OS) was not the same in different regions (P=0.021), and that the poorest OS was in Western Sichuan. This result may be related to the high rate of patients with palliative care.
conclusionsFor the last six years, the patients with lung cancer in Sichuan were mainly from Central Sichuan, male patients, elder (age > 60 yr) patients, and with adenocarcinoma of the lung. Patients of 2013 had lower rates of adenocarcinoma and squamous-cell carcinoma but higher rates of early-stage lung cancer and lymph-node metastasis. Furthermore, the 3-year OS was not the same in different regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.